Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes

Diabetes Care

Volumn 36, Issue 12, 2013, Pages 4157-4159

  Inkster, Berit ^a   Riha, Renata L ^a   Van Look, Liesbeth ^b   Williamson, Rachel ^b   McLachlan, Stela ^c   Frier, Brian M ^a   Strachan, Mark W J ^b   Price, Jackie F ^c   Reynolds, Rebecca M ^d  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGE; AGED; ARTICLE; BERLIN QUESTIONNAIRE; BODY MASS; DAYTIME SOMNOLENCE; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; EPWORTH SLEEPINESS SCALE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS; RISK FACTOR; SEX; SLEEP DISORDERED BREATHING; BLOOD; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; INCIDENCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SOMNOLENCE; UNITED KINGDOM;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; HYPOGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84891885434     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0863     Document Type: Article

References (15)

1. Graveling AJ, Frier BM. Hypoglycaemia: an overview. Prim Care Diabetes 2009;3: 131-139
2. Davis TME, Brown SGA, Jacobs IG, Bulsara M, Bruce DG, Davis WA. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab 2010;95:2240-2247
3. Inkster B, Zammitt NN, Frier BM. Druginduced hypoglycaemia in type 2 diabetes. Expert Opin Drug Saf 2012;11: 597-614
4. Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract 2010;87:64-68
5. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008;133: 496-506
6. Czeisler CA. Impact of sleepiness and sleep deficiency on public healthdutility of biomarkers. J Clin Sleep Med 2011;7 (Suppl.):S6-S8
7. Price JF, Reynolds RM, Mitchell RJ, et al. The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord 2008;8:18
8. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545
9. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131:485-491
10. Jauch-Chara K, Schultes B. Sleep and the response to hypoglycaemia. Best Pract Res Clin Endocrinol Metab 2010;24:801-815
11. Chico A, Vidal-Ríos P, Subirà M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-1157
12. Allen KV, Frier BM. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr Pract 2003;9:530-543
13. Bendtson I, Gade J, Thomsen CE, Rosenfalck A, Wildschiødtz G. Sleep disturbances in IDDM patients with nocturnal hypoglycemia. Sleep 1992;15:74-81
14. Banarer S, Cryer PE. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 2003;52:1195-1203
15. Czeisler CA. The Gordon Wilson Lecture: work hours, sleep and patient safety in residency training. Trans Am Clin Climatol Assoc 2006;117:159-188